Provides SGX945 Seven Years of U.S. Market Exclusivity Upon FDA Approval Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Office of Orphan Products Development of the United States (U.S.) Food […]

BitMine Crypto Holdings Exceed $6.612 billion, including 1.52 million ETH Tokens BitMine Crypto holdings of $6.6 billion ETH is a $1.7 billion increase from $4.9 billion reported last week BitMine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital

Mattr Appoints New Director GlobeNewswire August 18, 2025 TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced the appointment of Jane Skoblo as a director of the Company effective August 13, 2025. Ms. Skoblo will serve on both the Audit and Compensation & Organizational Development Committees of Mattr.

(Neo:MLC.NE),(Neo:MLC),(NASDAQ:TURN), 180 Degree Capital's shareholders to receive shares of New Mount Logan based on 110% of Net Asset Value (“NAV”) of 180 Degree Capital at closing, an increase from 100% of NAV New Mount Logan, together with its management, affiliates and related parties, commits to provide an aggregate of US$25 million for shareholder liquidity at

(NASDAQ:PDD), DUBLIN and SHANGHAI, Aug. 18, 2025 (GLOBE NEWSWIRE) — PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD) today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before U.S. markets open on Monday, August 25, 2025. The Company's management will hold an earnings conference

(TSX:TH),(NASDAQ:THTX), Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 per share, represents a compelling premium of 216% to the closing price on the Nasdaq on April 10, 2025, the date prior to the

(TSX:APS),(Pinksheets:APTOF),(PinkSheets:APTOF), Addition of Tuspetinib (TUS) to Venetoclax (VEN) and Azacitidine (AZA) is being developed as safe and mutation agnostic frontline therapy for AML Addition of TUS to VEN+AZA improves response rates; 100% CR/CRh at 80 mg and 120 mg Addition of TUS to VEN+AZA improves MRD-negativity rates; 78% among responders 100% CR/CRh in FLT3 wildtype

(NASDAQ:DALN), Shareholders to Receive All-Cash Consideration of $15 Per Share, a 242% Premium Over the Closing Price Per Share of Series A Common Stock on July 9, 2025 Hearst Merger Provides Accelerated ROI and Immediate Liquidity, While Eliminating Company Ownership Risks for Shareholders Recommends Shareholders to Vote “FOR” the Hearst Merger to Realize Certain Value

(NASDAQ:ONMD), MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced a long-term strategic partnership with Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in advanced cardiovascular imaging solutions. The collaboration reflects Circle CVI's commitment to leveraging trusted, high-quality data to drive

(NASDAQ:PSTV), REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures RNA sequencing and circulating tumor cell reduction consistent with tumor cell death No dose limiting toxicities were observed with an overall favorable safety profile HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a